Woodley Farra Manion Portfolio Management’s Bristol-Myers Squibb BMY Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,809	Closed	-$221K	–	101
2023 Q3	$221K	Hold	3,809	–	–	0.01%	91
2023 Q2	$244K	Hold	3,809	–	–	0.02%	90
2023 Q1	$264K	Sell	3,809 -798	-17%	-$56.3K	0.02%	85
2022 Q4	$331K	Hold	4,607	–	–	0.02%	76
2022 Q3	$328K	Hold	4,607	–	–	0.03%	74
2022 Q2	$357K	Buy	4,607 +1,007	+28%	+$76.7K	0.03%	73
2022 Q1	$263K	Sell	3,600 -863	-19%	-$57.9K	0.02%	88
2021 Q4	$278K	Buy	+4,463	New	+$262K	0.02%	91
2021 Q3	–	Sell	-5,665	Closed	-$379K	–	95
2021 Q2	$379K	Buy	5,665 +185	+3%	+$12.1K	0.03%	77
2021 Q1	$346K	Buy	5,480 +235	+4%	+$14.6K	0.03%	77
2020 Q4	$325K	Buy	5,245 +1,516	+41%	+$93.2K	0.03%	73
2020 Q3	$225K	Sell	3,729 -2,580	-41%	-$155K	0.02%	75
2020 Q2	$371K	Hold	6,309	–	–	0.04%	63
2020 Q1	$352K	Buy	6,309 +1,150	+22%	+$70.3K	0.04%	65
2019 Q4	$331K	Buy	5,159 +1,044	+25%	+$59.8K	0.03%	69
2019 Q3	$209K	Buy	+4,115	New	+$193K	0.02%	76
2019 Q2	–	Sell	-4,415	Closed	-$211K	–	80
2019 Q1	$211K	Buy	4,415 +400	+10%	+$19.9K	0.02%	74
2018 Q4	$209K	Sell	4,015 -200	-5%	-$10.7K	0.03%	72
2018 Q3	$262K	Hold	4,215	–	–	0.03%	74
2018 Q2	$233K	Hold	4,215	–	–	0.03%	77
2018 Q1	$267K	Sell	4,215 -200	-5%	-$12.9K	0.03%	74
2017 Q4	$271K	Hold	4,415	–	–	0.03%	76
2017 Q3	$281K	Hold	4,415	–	–	0.03%	78
2017 Q2	$246K	Hold	4,415	–	–	0.03%	71
2017 Q1	$240K	Sell	4,415 -950	-18%	-$52.1K	0.03%	72
2016 Q4	$314K	Hold	5,365	–	–	0.04%	69
2016 Q3	$289K	Buy	5,365 +215	+4%	+$13.8K	0.04%	70
2016 Q2	$379K	Hold	5,150	–	–	0.06%	65
2016 Q1	$329K	Hold	5,150	–	–	0.05%	70
2015 Q4	$354K	Hold	5,150	–	–	0.06%	69
2015 Q3	$305K	Sell	5,150 -11,640	-69%	-$738K	0.06%	58
2015 Q2	$1.12M	Sell	16,790 -3,000	-15%	-$198K	0.21%	50
2015 Q1	$1.28M	Hold	19,790	–	–	0.22%	51
2014 Q4	$1.17M	Sell	19,790 -150	-0.8%	-$8.46K	0.21%	52
2014 Q3	$1.02M	Sell	19,940 -2,700	-12%	-$135K	0.19%	53
2014 Q2	$1.1M	Sell	22,640 -33,196	-59%	-$1.64M	0.21%	54
2014 Q1	$2.9M	Sell	55,836 -1,215	-2%	-$64.7K	0.57%	28
2013 Q4	$3.03M	Sell	57,051 -558	-1%	-$28.4K	0.56%	28
2013 Q3	$2.67M	Buy	57,609 +1,741	+3%	+$76.4K	0.55%	28
2013 Q2	$2.5M	Buy	+55,868	New	+$2.43M	0.54%	27

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's BMY Position: Q4 2023 in Review

Woodley Farra Manion Portfolio Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,809 shares — an estimated $221K sold.

Woodley Farra Manion Portfolio Management first reported a position in BMY in Q2 2013 and held it in 40 quarters. The position peaked at $3.03M in Q4 2013. 2,364 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Woodley Farra Manion Portfolio Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Woodley Farra Manion Portfolio Management sold 3,809 Bristol-Myers Squibb shares in Q4 2023, an estimated $221K.
Woodley Farra Manion Portfolio Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 40 quarters.
Woodley Farra Manion Portfolio Management's Bristol-Myers Squibb position peaked at $3.03M in Q4 2013.
2,364 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q4 2023, filed 14 Feb 2024.